Genetix Biotherapeutics
The National Account Executive implements strategic payer engagement and access initiatives to ensure timely reimbursement for Genetix Biotherapeutics' gene therapy portfolio. This field-based role involves collaborating with treatment centers, negotiating value-based agreements, and partnering with commercial and government payers to streamline patient access pathways. The position requires deep expertise in payer strategy, contracting, and leadership within the specialty or gene therapy markets.
Headquarters
Somerville, Massachusetts, United States
Company Size
1-10 employees
Founded
1993
Genetix Biotherapeutics, formerly bluebird bio, is a biotechnology company focused on developing and commercializing transformative one-time genetic therapies for patients with rare diseases, including sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. The company markets three FDA-approved therapies—LYFGENIA, ZYNTEGLO, and SKYSONA—which are designed to treat the underlying genetic cause of disease using the patient's own blood stem cells. As a privately held company, Genetix Biotherapeutics is focused on commercial execution, scaling patient access, and improving the treatment experience for patients and providers.
Lonza and Genetix Biotherapeutics Extend Commercial Manufacturing Agreement for ZYNTEGLO
4 days ago
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots
Sep 18, 2025
After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics
Sep 18, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genetix Biotherapeutics.
Genetix Announces 2025 Commercial Performance Results and Outlines 2026 Strategic Priorities
1 week ago
National Account Director
Intellia Therapeutics
National Account Director, United/Optum
Intellia Therapeutics
Director National Accounts
Intellia Therapeutics
Vice President, US Market Access
Skyhawk Therapeutics
National Account Director, Express Scripts/Cigna
Intellia Therapeutics
Head of Payer Strategy and Partnerships
Alpaca Health